TOWA PHARMACEUTICAL COTT

TOWA PHARMACEUTICAL CO

2,770JPYD
+10+0.36%
At close at 06:25 GMT
JPY
No trades
See on Supercharts
Next report date
May 20
Report period
Q4 2024
EPS estimate
113.89 JPY
Revenue estimate
‪69.34 B‬ JPY
Market capitalization
‪135.83 B‬JPY
‪16.17 B‬JPY
‪227.93 B‬JPY
‪22.92 M‬
Beta (1Y)
0.83
Employees (FY)
‪4.59 K‬
Change (1Y)
+290 +6.75%
Revenue / Employee (1Y)
‪49.68 M‬JPY
Net income / Employee (1Y)
‪3.53 M‬JPY

About TOWA PHARMACEUTICAL CO


Headquarters
Kadoma
Founded
1951
ISIN
JP3623150004
FIGI
BBG000D9DCP7
Towa Pharmaceutical Co., Ltd. engages in the manufacture and distribution of pharmaceutical products. Its products include neurological and anti-allergic drugs, cardiovascular and respiratory drugs, gastrointestinal drugs, antibiotics and chemotherapeutic drugs, vitamins; hormone drugs, and other metabolic drugs. The company was founded in June 1951 and is headquartered in Osaka, Japan.
Performance
‪1.5%‬
‪4.0%‬
‪6.5%‬
‪9.0%‬
‪11.5%‬
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
‪‪20.00 B‬‬
‪‪40.00 B‬‬
‪‪60.00 B‬‬
‪‪80.00 B‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪0.00‬
‪‪20.00 B‬‬
‪‪40.00 B‬‬
‪‪60.00 B‬‬
‪‪80.00 B‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪0.00‬
‪‪20.00 B‬‬
‪‪40.00 B‬‬
‪‪60.00 B‬‬
‪‪80.00 B‬‬
Debt level and coverage
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪‪−80.00 B‬‬
‪0.00‬
‪‪80.00 B‬‬
‪‪160.00 B‬‬
‪‪240.00 B‬‬
Debt
Free cash flow
Cash & equivalents
Earnings
Next:May 20, 2025
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪−60.00‬
‪0.00‬
‪60.00‬
‪120.00‬
‪180.00‬
Actual
Estimate

No news here

Looks like there's nothing to report right now

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 4553 is 2,770 JPY — it has increased by 0.36% in the past 24 hours. Watch TOWA PHARMACEUTICAL CO stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange TOWA PHARMACEUTICAL CO stocks are traded under the ticker 4553.
4553 stock has risen by 1.09% compared to the previous week, the month change is a −10.65% fall, over the last year TOWA PHARMACEUTICAL CO has showed a −3.08% decrease.
We've gathered analysts' opinions on TOWA PHARMACEUTICAL CO future price: according to them, 4553 price has a max estimate of 4,600.00 JPY and a min estimate of 3,000.00 JPY. Watch 4553 chart and read a more detailed TOWA PHARMACEUTICAL CO stock forecast: see what analysts think of TOWA PHARMACEUTICAL CO and suggest that you do with its stocks.
4553 reached its all-time high on Oct 25, 2021 with the price of 3,560 JPY, and its all-time low was 623 JPY and was reached on Nov 17, 2004. View more price dynamics on 4553 chart.
See other stocks reaching their highest and lowest prices.
4553 stock is 0.76% volatile and has beta coefficient of 0.83. Track TOWA PHARMACEUTICAL CO stock price on the chart and check out the list of the most volatile stocks — is TOWA PHARMACEUTICAL CO there?
Today TOWA PHARMACEUTICAL CO has the market capitalization of ‪135.97 B‬, it has decreased by −2.87% over the last week.
Yes, you can track TOWA PHARMACEUTICAL CO financials in yearly and quarterly reports right on TradingView.
TOWA PHARMACEUTICAL CO is going to release the next earnings report on May 20, 2025. Keep track of upcoming events with our Earnings Calendar.
4553 earnings for the last quarter are 163.93 JPY per share, whereas the estimation was 57.66 JPY resulting in a 184.31% surprise. The estimated earnings for the next quarter are 113.89 JPY per share. See more details about TOWA PHARMACEUTICAL CO earnings.
TOWA PHARMACEUTICAL CO revenue for the last quarter amounts to ‪70.33 B‬ JPY, despite the estimated figure of ‪70.10 B‬ JPY. In the next quarter, revenue is expected to reach ‪69.34 B‬ JPY.
4553 net income for the last quarter is ‪8.07 B‬ JPY, while the quarter before that showed ‪1.06 B‬ JPY of net income which accounts for 661.23% change. Track more TOWA PHARMACEUTICAL CO financial stats to get the full picture.
TOWA PHARMACEUTICAL CO dividend yield was 2.07% in 2023, and payout ratio reached 18.26%. The year before the numbers were 3.17% and 134.18% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Mar 18, 2025, the company has ‪4.59 K‬ employees. See our rating of the largest employees — is TOWA PHARMACEUTICAL CO on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. TOWA PHARMACEUTICAL CO EBITDA is ‪42.49 B‬ JPY, and current EBITDA margin is 15.59%. See more stats in TOWA PHARMACEUTICAL CO financial statements.
Like other stocks, 4553 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TOWA PHARMACEUTICAL CO stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So TOWA PHARMACEUTICAL CO technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating TOWA PHARMACEUTICAL CO stock shows the neutral signal. See more of TOWA PHARMACEUTICAL CO technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.